Username Password
S&P 500: 2,126.06
Change: -0.22%

BIOGEN IDEC INC (BIIB)

Overview
Price 398.68
Price Change Today -$2.47 (-0.62%)
P&P rating Rating: 4
Open Price $399.19
Previous Close $401.15
Daily Range $397.40 - $401.79
52-Week Range $290.85 - $480.18
Volume 829
chart
Top Buy Analysis
BUY: BIIB Rating: 4
Company: BIOGEN IDEC INC
Points: 251.65
Start Price: $97.34
Start Date: 05/09/2011 11:45 PM
Neurodoc
Neurodoc
P&P Score: 99.24
Recs:
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Top Sell Analysis
No Sell Analysis. Be the First.
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

50 Buy
0 Sell
 
Try it Free!
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 12/23/14 BioTECH and Pharma / Drug manufactures being sold 1 12/23/14
rjm77me
99.99 07/23/14 If you have 100 stocks to watch during earning season = How will you track it 11 07/26/14
rjm77me
99.99 07/21/14 Zacks list of potential earning Beaters 6 07/24/14
rjm77me
99.99 04/24/14 Bio Tech leaders had lack luster earning results = $BIIB, AMGN, CELG 0
rjm77me
99.99 03/24/14 Charts, Stock Valuations some times have big divergences, In the end fundamentals have major influence 8 03/25/14
rjm77me
99.99 03/21/14 Momentum and Bio Tech on sale today 7 03/28/14
rjm77me
99.99 02/07/14 Is market ready to fly higher = coin toss between 2% gain or loss 0
rjm77me
99.99 11/07/13 Momentum stocks taken to wood shed today 4 11/20/13
rjm77me
99.99 06/12/13 $IBB head shoulder pattern confirmed 0
rjm77me
99.99 04/15/13 This was not a normal buy on pull back = it was a distribution day 3 04/21/13
Pages: [ 1 ]  2   3   4   5   ...  35  >>
Commentary
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +131.15
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +132.73
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +132.51
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +131.15
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +132.73
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +132.51
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +251.65
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +253.22
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +253.00
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +251.65
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +59.77% +131.15 view
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +58.19% +132.73 view
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +58.41% +132.51 view
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +59.77% +131.15 view
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +58.19% +132.73 view
JDShots 0.30 BUY One to Three Months 05/15/2012 $137.04 $398.68
(-0.62%)
+190.92% +58.41% +132.51 view
vip 0.80 BUY One to Three Months 01/26/2012 $117.85 $398.68
(-0.62%)
+238.29% +61.26% +177.04
vip 0.80 BUY One to Three Months 01/26/2012 $117.85 $398.68
(-0.62%)
+238.29% +59.66% +178.64
vip 0.80 BUY One to Three Months 01/26/2012 $117.85 $398.68
(-0.62%)
+238.29% +59.88% +178.41
vip 0.80 BUY One to Three Months 01/26/2012 $117.85 $398.68
(-0.62%)
+238.29% +61.26% +177.04
Pages: [ 1 ]  2   3   4   5  >>
Sponsored Links